![Joseph Frattaroli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Joseph Frattaroli is the founder of Flagship Consulting, Inc. (founded in 2010).
He was the President, Chief Executive & Financial Officer at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He is currently the Chief Financial Officer at Inhibikase Therapeutics, Inc. (2018-2024).
Mr. Frattaroli obtained his undergraduate degree from Salem State University.
Anciens postes connus de Joseph Frattaroli
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur Financier/CFO | 31/03/2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Commercializes, markets and sells pharmaceutical products | Directeur Financier/CFO | 06/11/2012 |
Flagship Consulting, Inc. | Fondateur | - |
Formation de Joseph Frattaroli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Commercializes, markets and sells pharmaceutical products | Health Technology |
Salem State University
 Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Flagship Consulting, Inc. |
